Cardiovascular Risk Reduction Clinic (CRRC) for enhanced management of atherosclerotic cardiovascular disease,

01 Nov 2023
Cardiovascular Risk Reduction Clinic (CRRC) for enhanced management of atherosclerotic cardiovascular
disease,
Atherosclerotic cardiovascular disease (ASCVD) is aetiologic for acute cardiovascular (CV) events such as myocardial infarction, ischaemic stroke, unstable angina and death. CV diseases (CVDs), mainly ischaemic heart disease (IHD) and stroke, are the leading causes of mortality and morbidity worldwide, with CV deaths reaching 18.6 million in 2019. In Malaysia, IHD and cerebrovascular diseases are the principal causes of mortality in 2021, accounting for 13.7% and 6.5% of total deaths, respectively.
Sponsored as an educational program by Novartis Corporation (Malaysia) Sdn Bhd

Resources

MY-NOV-337

MY-NOV-337

MY-NOV-337

MY-NOV-337